NSEAnalysts/Institutional Investor Meet/Con. Call Updates10 Jul 2026 · 10 Jul 2026, 07:45 pm

Analysts/Institutional Investor Meet/Con. Call Updates

Tatva Chintan Pharma Chem Limited · TATVA

✦ AI SummaryResults

Tatva Chintan Pharma Chem Limited has informed the Exchange about the schedule of an earnings call post announcement of financial results for the quarter ended 30 June 2026. The call is hosted by ICICI Securities and is scheduled on Friday, 17 July 2026, at 05:00 p.m. (IST).

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Tatva Chintan Pharma Chem Limited has informed the Exchange about Schedule of meet

Attachments (1)

📄

TATVA_10072026194304_I.pdf

pdf

Download →
View document text
Date: 10 July 2026 Ref. No.: TCPCL/SEC/2026-27/00019 The General Manager, The Manager, Corporate relationship department, Listing department, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Fort, Bandra-Kurla Complex, Bandra(E), Mumbai-400 001 Mumbai-400 051 Scrip Code: 543321 Scrip Symbol: TATVA Subject: Intimation of Schedule of Earnings Call Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we would like to inform you that the Earnings Call post announcement of financial results of the Company for the quarter ended 30 June 2026, is scheduled on Friday, 17 July 2026, at 05:00 p.m. (IST). The Call is hosted by ICICI Securities and an invite in this regard is attached for your information and records. The above information shall be uploaded on the website of the Company at www.tatvachintan.com. Kindly take the above intimation on your record and oblige. Thanking you, Yours faithfully, For Tatva Chintan Pharma Chem Limited Ishwar Nayi Company Secretary and Compliance Officer M. No.: A37444 Encl.: As above is pleased to invite you to the Q1FY27 Results Conference Call Tatva Chintan Pharma Chem Limited Represented by Mr. Chintan Shah, Managing Director Mr. Ajesh Pillai, Chief Financial Officer Friday, July 17, 2026 at 17:00 hrs India Time Diamond Pass registration link: Copy this Link in your browser: Link Call Co-ordinator: Mr. Jaideep Goswami, Head of Equities: Email: Jaideep.goswami@icicisecurities.com Mr. Sanjesh Jain: Phone: +91 22 6807 7153, e-mail: sanjesh.jain@icicisecurities.com Mr. Mohit Mishra: Phone: +91 22 6807 7637, e-mail: mohit.mishra@icicisecurities.com For any clarification, please contact: Mr. Rushad Kapadia: Phone: +91 22 6807 7334, e-mail: rushad.Kapadia@icicisecurities.com Ms. Seema Sehgal: Phone: +91 9871116926, e-mail: seema.sehgal@icicisecurities.com Ms. Minali Ginwala: Phone: +91 22 6807 7454, e-mail: minali.ginwala@icicisecurities.com